03/10/2015 - 1:19pm

Actavis expanded its portfolio of topicals with the launch of a generic corticosteroid.

03/06/2015 - 11:37am

The Food and Drug Administration approved Zarxio, making it the first approved biosimilar product in the United States.

03/04/2015 - 6:28pm

While the big four analgesic manufacturers — Bayer, Pfizer, McNeil and Novartis — command the lion’s share of retail ad support behind their mega analgesic brands, Prestige Brands and BedRock Brands are making headway promoting their niche pain relieving products.

03/04/2015 - 6:28pm

Almost half of all circular ads in support of a digestive remedy promote an antacid tablet. 

03/04/2015 - 6:28pm

According to ECRM’s analysis of circular retail promotions for allergy, Chattem emerged as the leading advertiser of allergy remedies.

03/04/2015 - 6:28pm

Chattem’s launch of the first nasal corticosteroid onto OTC shelves represented the most significant success story in the cough-cold-allergy space in the past year. 

03/04/2015 - 6:28pm

Immunity boosters and hand sanitizer are on most shopping lists as consumers prepare their families for the inevitable sniffles, sneezes and coughs associated with the cold and flu season.

03/04/2015 - 6:28pm

There was a $1.1 billion gain in OTC sales between 2013 and 2014, according to data culled from IRI, some $500 million of which can be attributed to an increase in sales across all cough-cold/allergy/sinus products and an approximate $300 million to a rise in digestive sales.

02/27/2015 - 5:25pm

Epic Pharma on Friday launched two generics: a schedule II pain reliever and a calcium channel blocker.